- Home
- BBAI vs TARS Comparison
BBAI vs TARS Comparison
Compare BBAI & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- TARS
- Stock Information
- Founded
- BBAI 2020
- TARS 2016
- Country
- BBAI United States
- TARS United States
- Employees
- BBAI N/A
- TARS N/A
- Industry
- BBAI EDP Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- BBAI Technology
- TARS Health Care
- Exchange
- BBAI Nasdaq
- TARS Nasdaq
- Market Cap
- BBAI 1.7B
- TARS 1.7B
- IPO Year
- BBAI N/A
- TARS 2020
- Fundamental
- Price
- BBAI $7.38
- TARS $41.50
- Analyst Decision
- BBAI Strong Buy
- TARS Strong Buy
- Analyst Count
- BBAI 3
- TARS 7
- Target Price
- BBAI $6.17
- TARS $67.14
- AVG Volume (30 Days)
- BBAI 170.7M
- TARS 571.2K
- Earning Date
- BBAI 08-11-2025
- TARS 08-07-2025
- Dividend Yield
- BBAI N/A
- TARS N/A
- EPS Growth
- BBAI N/A
- TARS N/A
- EPS
- BBAI N/A
- TARS N/A
- Revenue
- BBAI $159,872,000.00
- TARS $233,674,000.00
- Revenue This Year
- BBAI $8.26
- TARS $122.94
- Revenue Next Year
- BBAI $12.09
- TARS $44.14
- P/E Ratio
- BBAI N/A
- TARS N/A
- Revenue Growth
- BBAI 9.40
- TARS 449.03
- 52 Week Low
- BBAI $1.17
- TARS $20.08
- 52 Week High
- BBAI $10.36
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- BBAI 57.73
- TARS 49.39
- Support Level
- BBAI $6.90
- TARS $41.50
- Resistance Level
- BBAI $8.06
- TARS $43.33
- Average True Range (ATR)
- BBAI 0.75
- TARS 1.63
- MACD
- BBAI -0.08
- TARS 0.23
- Stochastic Oscillator
- BBAI 48.86
- TARS 42.86
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.